153 related articles for article (PubMed ID: 38748502)
1. Healthcare challenges in LMICs: addressing antibiotic resistance threats, a call for comprehensive global solutions: an editorial.
Ali T; Habib A; Nazir Z; Ali M; Haque MA
Int J Surg; 2024 May; 110(5):3085-3087. PubMed ID: 38748502
[No Abstract] [Full Text] [Related]
2. Antibiotic resistance in low- and middle-income countries: current practices and its global implications.
Al Meslamani AZ
Expert Rev Anti Infect Ther; 2023; 21(12):1281-1286. PubMed ID: 37804134
[TBL] [Abstract][Full Text] [Related]
3. Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries.
Nadimpalli M; Delarocque-Astagneau E; Love DC; Price LB; Huynh BT; Collard JM; Lay KS; Borand L; Ndir A; Walsh TR; Guillemot D;
Clin Infect Dis; 2018 Mar; 66(6):963-969. PubMed ID: 29346620
[TBL] [Abstract][Full Text] [Related]
4. Strategies to improve antibiotic access and a way forward for lower middle-income countries.
Wasan H; Reeta KH; Gupta YK
J Antimicrob Chemother; 2024 Jan; 79(1):1-10. PubMed ID: 38008421
[TBL] [Abstract][Full Text] [Related]
5. The role of healthcare strategies in controlling antibiotic resistance.
Aziz AM
Br J Nurs; 2013 Oct 10-23; 22(18):1066-74. PubMed ID: 24121851
[TBL] [Abstract][Full Text] [Related]
6. Surgical Infections in Low- and Middle-Income Countries: A Global Assessment of the Burden and Management Needs.
Rickard J; Beilman G; Forrester J; Sawyer R; Stephen A; Weiser TG; Valenzuela J
Surg Infect (Larchmt); 2020 Aug; 21(6):478-494. PubMed ID: 31816263
[No Abstract] [Full Text] [Related]
7. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
Ashley EA; Recht J; Chua A; Dance D; Dhorda M; Thomas NV; Ranganathan N; Turner P; Guerin PJ; White NJ; Day NP
J Antimicrob Chemother; 2018 Jul; 73(7):1737-1749. PubMed ID: 29514279
[TBL] [Abstract][Full Text] [Related]
8. How can we tackle the overuse of antibiotics in low- and middle-income countries?
Sulis G; Sayood S; Gandra S
Expert Rev Anti Infect Ther; 2023; 21(11):1189-1201. PubMed ID: 37746828
[TBL] [Abstract][Full Text] [Related]
9. The twin challenges of longevity and climate change in controlling antimicrobial resistance.
Shafaati M; Salehi M; Zare M
J Antibiot (Tokyo); 2024 Jul; 77(7):399-402. PubMed ID: 38724628
[TBL] [Abstract][Full Text] [Related]
10. Healthcare for older people in lower and middle income countries.
Tan MP
Age Ageing; 2022 Apr; 51(4):. PubMed ID: 35373815
[TBL] [Abstract][Full Text] [Related]
11. True impact of antibiotic resistance on treatment outcomes and the cost of healthcare delivery. Editorial.
Finch RG
Curr Opin Infect Dis; 2011 Apr; 24(2):95-6. PubMed ID: 21311325
[No Abstract] [Full Text] [Related]
12. Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys.
Fink G; D'Acremont V; Leslie HH; Cohen J
Lancet Infect Dis; 2020 Feb; 20(2):179-187. PubMed ID: 31843383
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic stewardship in low- and middle-income countries: the same but different?
Cox JA; Vlieghe E; Mendelson M; Wertheim H; Ndegwa L; Villegas MV; Gould I; Levy Hara G
Clin Microbiol Infect; 2017 Nov; 23(11):812-818. PubMed ID: 28712667
[TBL] [Abstract][Full Text] [Related]
14. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.
Meara JG; Leather AJ; Hagander L; Alkire BC; Alonso N; Ameh EA; Bickler SW; Conteh L; Dare AJ; Davies J; Mérisier ED; El-Halabi S; Farmer PE; Gawande A; Gillies R; Greenberg SL; Grimes CE; Gruen RL; Ismail EA; Kamara TB; Lavy C; Lundeg G; Mkandawire NC; Raykar NP; Riesel JN; Rodas E; Rose J; Roy N; Shrime MG; Sullivan R; Verguet S; Watters D; Weiser TG; Wilson IH; Yamey G; Yip W
Lancet; 2015 Aug; 386(9993):569-624. PubMed ID: 25924834
[No Abstract] [Full Text] [Related]
15. Evidence of factors influencing self-medication with antibiotics in LMICs: a systematic scoping review protocol.
Torres NF; Chibi B; Middleton LE; Solomon VP; Mashamba-Thompson T
Syst Rev; 2018 Jul; 7(1):102. PubMed ID: 30031404
[TBL] [Abstract][Full Text] [Related]
16. Improving antibiotic use through behaviour change: a systematic review of interventions evaluated in low- and middle-income countries.
Cuevas C; Batura N; Wulandari LPL; Khan M; Wiseman V
Health Policy Plan; 2021 Jun; 36(5):594-605. PubMed ID: 33822953
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance in developing countries.
Shibl AM; Memish Z; Osoba A
J Chemother; 2001 Apr; 13 Suppl 1():40-4. PubMed ID: 11434528
[TBL] [Abstract][Full Text] [Related]
18. Resetting the agenda for antibiotic resistance through a health systems perspective.
Cars O; Chandy SJ; Mpundu M; Peralta AQ; Zorzet A; So AD
Lancet Glob Health; 2021 Jul; 9(7):e1022-e1027. PubMed ID: 34143980
[TBL] [Abstract][Full Text] [Related]
19. Anti-Microbial Resistance In Pakistan: A Public Health Issue.
Shaikh BT
J Ayub Med Coll Abbottabad; 2017; 29(2):184-185. PubMed ID: 28718227
[TBL] [Abstract][Full Text] [Related]
20. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review.
Luchen CC; Chibuye M; Spijker R; Simuyandi M; Chisenga C; Bosomprah S; Chilengi R; Schultsz C; Mende DR; Harris VC
PLoS Med; 2023 Jun; 20(6):e1004235. PubMed ID: 37368871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
